
Dr. Moxit Shah, DM Endocrinology | Endocrinologist in Ahmedabad
GLP-1 injections have become an important option in medical weight management. Medicines such as semaglutide and tirzepatide can reduce appetite, increase fullness and support clinically meaningful weight loss in appropriately selected patients. However, these medicines work best when treatment is individualized, doses are increased gradually and nutrition and physical activity remain part of the plan.
What Are GLP-1 Injections?
GLP-1 stands for glucagon-like peptide-1, a hormone involved in appetite, insulin secretion, glucagon regulation and gastric emptying. GLP-1 receptor agonists mimic some of these effects. Tirzepatide works on both GIP and GLP-1 receptors and is therefore a dual incretin medicine.

How Do GLP-1 Injections Help With Weight Loss?
- Reduce appetite: Hunger may decrease, making it easier to follow an appropriate calorie deficit.
- Increase satiety: People may feel satisfied with smaller portions.
- Slow gastric emptying: This can contribute to a longer feeling of fullness.
- Improve glucose regulation: These medicines can improve glycemic control in appropriate patients with type 2 diabetes.
- Support long-term weight management: When effective and tolerated, treatment can be incorporated into a broader chronic weight-management plan.
Who Should Consider GLP-1 Injections for Weight Loss?
Weight-loss medication is not appropriate for everyone who wants to lose a few kilograms. Depending on the specific medicine and local approval, pharmacological treatment may be considered for adults with obesity or for people with overweight together with weight-related medical conditions. The FDA-approved weight-management indication for tirzepatide, for example, includes adults with obesity or overweight with at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. citeturn0search0
Your endocrinologist should consider BMI and waist-related risk together with diabetes or prediabetes, blood pressure, lipid abnormalities, sleep apnea, fatty liver disease, medications, gastrointestinal history and other individual factors.
Semaglutide vs Tirzepatide
Semaglutide is a GLP-1 receptor agonist. Tirzepatide activates both GIP and GLP-1 receptors. Both can be effective, but treatment choice should not be based only on the largest number reported in a clinical trial. Medical history, treatment goals, tolerability, contraindications, availability and cost all matter.
For a detailed comparison, see Semaglutide vs Tirzepatide for Weight Loss.
What Happens During the First Few Weeks?
GLP-1 treatment is generally started at a lower dose and increased gradually according to the specific medicine’s prescribing information. The aim is to allow the body to adjust and improve gastrointestinal tolerability. Dose escalation should not be accelerated simply because weight loss appears slower than expected.

Common Side Effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Bloating or abdominal discomfort
- Indigestion or reflux symptoms
- Reduced appetite
Gastrointestinal symptoms are particularly common during treatment initiation and dose escalation. Eating smaller meals, eating slowly and maintaining hydration may help. Persistent vomiting, severe abdominal pain, dehydration or other concerning symptoms require medical assessment. FDA labeling for semaglutide and tirzepatide contains important warnings and contraindications that should be reviewed before treatment. citeturn0search5turn0search0
Read more: GLP-1 Side Effects: What to Expect and How to Manage Them.
How Can You Protect Muscle During GLP-1 Weight Loss?
Weight loss can include both fat mass and lean mass. A good medical weight-management plan therefore pays attention to adequate protein intake, resistance exercise, physical activity and overall nutrition rather than focusing only on the number on the weighing scale.
Dietary advice should be individualized, particularly in people with diabetes, kidney disease, gastrointestinal symptoms or other medical conditions. See our GLP-1 diet guide for practical nutrition principles.
Important: Do Not Self-Medicate With Unapproved GLP-1 Products
Patients should be cautious about buying semaglutide or tirzepatide online without a prescription or using products of uncertain origin. The FDA has recently highlighted concerns involving unapproved GLP-1 products, including fraudulent products and dosing errors with some compounded preparations. The agency recommends obtaining prescription medicines through appropriate medical and pharmacy channels. citeturn0search1
Who Should Not Use These Medicines Without Specialist Assessment?
Important contraindications and precautions vary by medicine. For example, the current U.S. prescribing information for Wegovy states that it should not be used in people with a personal or family history of medullary thyroid carcinoma or in people with multiple endocrine neoplasia syndrome type 2. Other clinical situations, including certain gastrointestinal conditions, pregnancy and interactions with other medicines, also require careful assessment. citeturn0search5
What If You Stop a GLP-1 Medicine?
Weight management is usually a long-term process. Some people regain weight after effective pharmacological treatment is stopped, particularly when appetite returns. The decision to continue, adjust or stop treatment should therefore be made with your treating physician and should consider your long-term weight-management strategy.
Read more: What Happens When You Stop GLP-1 Medicines?
Frequently Asked Questions
Do GLP-1 injections directly burn fat?
The main effect is not direct fat burning. By reducing appetite and food intake, these medicines can help create a sustained energy deficit that leads to weight loss.
Can someone without diabetes use a GLP-1 medicine for weight loss?
Yes, certain medicines in this class are approved for chronic weight management in eligible people without diabetes. The exact indication depends on the medicine and the applicable regulatory approval.
How quickly will I lose weight?
Response varies. Appetite changes may occur early, while clinically meaningful weight loss usually develops progressively over weeks and months as treatment is titrated and lifestyle measures are maintained.
Can I increase the dose faster to lose weight faster?
No. Dose escalation should follow the prescribing information and your clinician’s treatment plan. Faster escalation can increase adverse effects and is not a substitute for individualized care.
Medical Weight Loss in Ahmedabad
Dr. Moxit Shah, DM Endocrinology provides specialist evaluation and management for Diabetes, Thyroid disorders and Medical Weight Loss at Vishuddha Endocrine Clinic, Ahmedabad.
Vishuddha Endocrine Clinic
Elite Magnum, Bhuyangdev Cross Road, Memnagar/Ghatlodia, Ahmedabad
Appointments: +91 99799 92797
This article is for educational purposes and does not replace an individual medical consultation. GLP-1 medicines are prescription treatments and should be used under appropriate medical supervision.